{"transactions":[{"id":730131,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-22T20:32:40.000Z","date":"2026-06-19","kind":"grant","planned":false,"acquired":true,"shares":989,"price":15.63,"value":15458.07,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees."}],"balance_after":23039,"source":{"system":"sec-edgar","filing":"0001856296-26-000007","document":"wk-form4_1782160357.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528287/000185629626000007/wk-form4_1782160357.xml","form_type":"4"}},{"id":747540,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T21:10:17.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":5368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable, subject to the Reporting Person's continuous service through each vesting date."}],"balance_after":5368,"derivative":{"exercise_price":15.74,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":5368},"source":{"system":"sec-edgar","filing":"0001856296-26-000005","document":"wk-form4_1780693812.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1528287/000185629626000005/wk-form4_1780693812.xml","form_type":"4"}},{"id":747539,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T21:10:17.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":2890,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares shall vest in twelve (12) equal consecutive monthly installments until all of the shares are fully vested, subject to the Reporting Person's continuous service through each vesting date."}],"balance_after":22050,"source":{"system":"sec-edgar","filing":"0001856296-26-000005","document":"wk-form4_1780693812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528287/000185629626000005/wk-form4_1780693812.xml","form_type":"4"}},{"id":830607,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-23T20:42:40.000Z","date":"2026-03-20","kind":"grant","planned":false,"acquired":true,"shares":1153,"price":13,"value":14989.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees."}],"balance_after":19160,"source":{"system":"sec-edgar","filing":"0001856296-26-000003","document":"wk-form4_1774298557.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528287/000185629626000003/wk-form4_1774298557.xml","form_type":"4"}},{"id":959373,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-23T21:15:30.000Z","date":"2025-12-19","kind":"grant","planned":false,"acquired":true,"shares":904,"price":16.59,"value":14997.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees."}],"balance_after":18007,"source":{"system":"sec-edgar","filing":"0001856296-25-000005","document":"form4-12232025_041221.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528287/000185629625000005/form4-12232025_041221.xml","form_type":"4"}},{"id":1034238,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-22T23:30:07.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":1509,"price":9.94,"value":14999.46,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees."}],"balance_after":17103,"source":{"system":"sec-edgar","filing":"0001856296-25-000003","document":"form4-09222025_070904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528287/000185629625000003/form4-09222025_070904.xml","form_type":"4"}},{"id":1102439,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T20:30:13.000Z","date":"2025-06-21","kind":"grant","planned":false,"acquired":true,"shares":1440,"price":10.41,"value":14990.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees."}],"balance_after":15594,"source":{"system":"sec-edgar","filing":"0001415889-25-018089","document":"form4-06242025_040603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1528287/000141588925018089/form4-06242025_040603.xml","form_type":"4"}},{"id":1102438,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T20:30:13.000Z","date":"2025-03-21","kind":"grant","planned":false,"acquired":true,"shares":1247,"price":12.02,"value":14988.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees."}],"balance_after":14154,"source":{"system":"sec-edgar","filing":"0001415889-25-018089","document":"form4-06242025_040603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1528287/000141588925018089/form4-06242025_040603.xml","form_type":"4"}},{"id":1102437,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T20:30:13.000Z","date":"2024-12-21","kind":"grant","planned":false,"acquired":true,"shares":1300,"price":11.53,"value":14989.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees."}],"balance_after":12907,"source":{"system":"sec-edgar","filing":"0001415889-25-018089","document":"form4-06242025_040603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1528287/000141588925018089/form4-06242025_040603.xml","form_type":"4"}},{"id":1102436,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T20:30:13.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":2152,"price":6.97,"value":14999.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees."}],"balance_after":11607,"source":{"system":"sec-edgar","filing":"0001415889-25-018089","document":"form4-06242025_040603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1528287/000141588925018089/form4-06242025_040603.xml","form_type":"4"}},{"id":1102435,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T20:30:13.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":1984,"price":7.56,"value":14999.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees."}],"balance_after":9455,"source":{"system":"sec-edgar","filing":"0001415889-25-018089","document":"form4-06242025_040603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1528287/000141588925018089/form4-06242025_040603.xml","form_type":"4"}},{"id":1102434,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T20:30:13.000Z","date":"2024-03-29","kind":"grant","planned":false,"acquired":true,"shares":1136,"price":13.2,"value":14995.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees."}],"balance_after":7471,"source":{"system":"sec-edgar","filing":"0001415889-25-018089","document":"form4-06242025_040603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1528287/000141588925018089/form4-06242025_040603.xml","form_type":"4"}},{"id":1102433,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T20:30:13.000Z","date":"2023-12-29","kind":"grant","planned":false,"acquired":true,"shares":1454,"price":10.31,"value":14990.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees."}],"balance_after":6335,"source":{"system":"sec-edgar","filing":"0001415889-25-018089","document":"form4-06242025_040603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1528287/000141588925018089/form4-06242025_040603.xml","form_type":"4"}},{"id":1102432,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T20:30:13.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":1541,"price":9.73,"value":14993.93,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees."}],"balance_after":4881,"source":{"system":"sec-edgar","filing":"0001415889-25-018089","document":"form4-06242025_040603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1528287/000141588925018089/form4-06242025_040603.xml","form_type":"4"}},{"id":1102431,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T20:30:13.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":3340,"price":4.49,"value":14996.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees."}],"balance_after":3340,"source":{"system":"sec-edgar","filing":"0001415889-25-018089","document":"form4-06242025_040603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528287/000141588925018089/form4-06242025_040603.xml","form_type":"4"}},{"id":1117493,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-09T21:26:09.000Z","date":"2025-06-06","kind":"grant","planned":false,"acquired":true,"shares":8745,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable, subject to the Reporting Person's continuous service through each vesting date."}],"balance_after":8745,"derivative":{"exercise_price":13.15,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":8745},"source":{"system":"sec-edgar","filing":"0001415889-25-016328","document":"form4-06092025_050610.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528287/000141588925016328/form4-06092025_050610.xml","form_type":"4"}},{"id":1249509,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2025-02-25T02:00:43.000Z","date":"2025-02-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":958,"price":10.72,"value":10269.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the \"net settlement\" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs."}],"balance_after":162306,"source":{"system":"sec-edgar","filing":"0001140361-25-005719","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036125005719/form4.xml","form_type":"4"}},{"id":1263767,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-19T02:00:26.000Z","date":"2025-02-13","kind":"exercise","planned":false,"acquired":false,"shares":187500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2022. These options vest and become exercisable (i) 25% on the first anniversary of the applicable vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject generally to the reporting person's continuous service through each vesting date (unless otherwise provided in the applicable award documentation)."}],"balance_after":312500,"derivative":{"exercise_price":3.85,"expiration_date":"2032-04-19","underlying":"Common Stock","underlying_shares":187500},"source":{"system":"sec-edgar","filing":"0001140361-25-005053","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036125005053/form4.xml","form_type":"4"}},{"id":1263766,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2025-02-19T02:00:26.000Z","date":"2025-02-13","kind":"sale","planned":false,"acquired":false,"shares":227500,"price":10.43,"value":2372825.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range."}],"balance_after":163264,"source":{"system":"sec-edgar","filing":"0001140361-25-005053","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036125005053/form4.xml","form_type":"4"}},{"id":1263765,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2025-02-19T02:00:26.000Z","date":"2025-02-13","kind":"exercise","planned":false,"acquired":true,"shares":187500,"price":3.85,"value":721875.0,"ownership":{"direct":true},"balance_after":390764,"source":{"system":"sec-edgar","filing":"0001140361-25-005053","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036125005053/form4.xml","form_type":"4"}},{"id":1297537,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2025-01-23T02:04:04.000Z","date":"2025-01-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":1057,"price":11.15,"value":11785.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the \"net settlement\" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs."}],"balance_after":203264,"source":{"system":"sec-edgar","filing":"0001140361-25-001663","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036125001663/form4.xml","form_type":"4"}},{"id":1321648,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2024-12-27T02:00:39.000Z","date":"2024-12-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":3087,"price":11.57,"value":35716.59,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the \"net settlement\" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs."}],"balance_after":204321,"source":{"system":"sec-edgar","filing":"0001140361-24-050459","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036124050459/form4.xml","form_type":"4"}},{"id":1354235,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2024-11-23T02:00:14.000Z","date":"2024-11-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":958,"price":11.49,"value":11007.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the \"net settlement\" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs."}],"balance_after":207408,"source":{"system":"sec-edgar","filing":"0001140361-24-047698","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036124047698/form4.xml","form_type":"4"}},{"id":1382910,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2024-10-23T01:00:28.000Z","date":"2024-10-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":956,"price":11.92,"value":11395.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the \"net settlement\" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs."}],"balance_after":208366,"source":{"system":"sec-edgar","filing":"0001140361-24-043961","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036124043961/form4.xml","form_type":"4"}},{"id":1400106,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-25T01:01:00.000Z","date":"2024-09-23","kind":"exercise","planned":true,"acquired":false,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2022. These options vest and become exercisable (i) 25% on the first anniversary of the applicable vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject generally to the reporting person's continuous service through each vesting date (unless otherwise provided in the applicable award documentation)."}],"balance_after":500000,"derivative":{"exercise_price":3.85,"expiration_date":"2032-04-19","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001140361-24-041789","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036124041789/form4.xml","form_type":"4"}},{"id":1400105,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2024-09-25T01:01:00.000Z","date":"2024-09-23","kind":"sale","planned":true,"acquired":false,"shares":250000,"price":11.89,"value":2972500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range."}],"balance_after":209322,"source":{"system":"sec-edgar","filing":"0001140361-24-041789","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036124041789/form4.xml","form_type":"4"}},{"id":1400104,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2024-09-25T01:01:00.000Z","date":"2024-09-23","kind":"exercise","planned":true,"acquired":true,"shares":250000,"price":3.85,"value":962500.0,"ownership":{"direct":true},"balance_after":459322,"source":{"system":"sec-edgar","filing":"0001140361-24-041789","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036124041789/form4.xml","form_type":"4"}},{"id":1400103,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2024-09-25T01:01:00.000Z","date":"2024-09-20","kind":"tax_withholding","planned":true,"acquired":false,"shares":3087,"price":11.97,"value":36951.39,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the \"net settlement\" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs."}],"balance_after":209322,"source":{"system":"sec-edgar","filing":"0001140361-24-041789","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036124041789/form4.xml","form_type":"4"}},{"id":1425282,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2024-08-23T01:00:32.000Z","date":"2024-08-20","kind":"tax_withholding","planned":true,"acquired":false,"shares":958,"price":11.48,"value":10997.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the \"net settlement\" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs."}],"balance_after":212409,"source":{"system":"sec-edgar","filing":"0001140361-24-038307","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036124038307/form4.xml","form_type":"4"}},{"id":1448665,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2024-07-26T01:00:56.000Z","date":"2024-07-20","kind":"tax_withholding","planned":true,"acquired":false,"shares":958,"price":11,"value":10538.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the \"net settlement\" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes Common Shares purchased under the Company's Employee Stoch Purchase Plan."}],"balance_after":213367,"source":{"system":"sec-edgar","filing":"0001140361-24-034283","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036124034283/form4.xml","form_type":"4"}},{"id":1470660,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2024-06-25T01:00:34.000Z","date":"2024-06-20","kind":"tax_withholding","planned":true,"acquired":false,"shares":3087,"price":10.8,"value":33339.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the \"net settlement\" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs."}],"balance_after":212123,"source":{"system":"sec-edgar","filing":"0001140361-24-031175","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036124031175/form4.xml","form_type":"4"}},{"id":1483060,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Rt to Buy)","published_at":"2024-06-11T20:17:53.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":17774,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable."}],"balance_after":17774,"derivative":{"exercise_price":6.47,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":17774},"source":{"system":"sec-edgar","filing":"0001415889-24-016361","document":"form4-06112024_080649.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528287/000141588924016361/form4-06112024_080649.xml","form_type":"4"}},{"id":1505448,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2024-05-23T01:01:33.000Z","date":"2024-05-20","kind":"tax_withholding","planned":true,"acquired":false,"shares":1363,"price":11.37,"value":15497.31,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the \"net settlement\" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs."}],"balance_after":215210,"source":{"system":"sec-edgar","filing":"0001140361-24-027207","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036124027207/form4.xml","form_type":"4"}},{"id":1536150,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-25T01:12:02.000Z","date":"2024-04-22","kind":"grant","planned":false,"acquired":true,"shares":230548,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2024. These options vest and become exercisable (i) 25% on the first anniversary of the vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date."}],"balance_after":230548,"derivative":{"exercise_price":10.6,"expiration_date":"2034-04-21","underlying":"Common Shares","underlying_shares":230548},"source":{"system":"sec-edgar","filing":"0001140361-24-021818","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036124021818/form4.xml","form_type":"4"}},{"id":1536149,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2024-04-25T01:12:02.000Z","date":"2024-04-22","kind":"grant","planned":false,"acquired":false,"shares":38685,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an award of 38,685 restricted stock units with respect to Common Shares (\"RSUs\") with a vesting commencement date of April 20, 2024. 1/4 of the RSUs service-vest on the date thirteen (13) months from the vesting commencement date; and the balance of the RSUs service-vest in series of twelve (12) successive equal quarterly installments measured from the date thirteen (13) months from the vesting commencement date, subject to the reporting person's Continuous Service through the applicable vesting date."}],"balance_after":216573,"source":{"system":"sec-edgar","filing":"0001140361-24-021818","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036124021818/form4.xml","form_type":"4"}},{"id":1536845,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2024-04-24T01:00:58.000Z","date":"2024-04-20","kind":"tax_withholding","planned":true,"acquired":false,"shares":9881,"price":10.46,"value":103355.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the \"net settlement\" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs."}],"balance_after":177888,"source":{"system":"sec-edgar","filing":"0001140361-24-021493","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036124021493/form4.xml","form_type":"4"}},{"id":1563328,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2024-03-23T01:00:50.000Z","date":"2024-03-20","kind":"tax_withholding","planned":true,"acquired":false,"shares":1506,"price":10.01,"value":15075.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the \"net settlement\" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs."}],"balance_after":187769,"source":{"system":"sec-edgar","filing":"0001140361-24-014895","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036124014895/form4.xml","form_type":"4"}},{"id":1625344,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2024-02-23T02:01:45.000Z","date":"2024-02-20","kind":"tax_withholding","planned":true,"acquired":false,"shares":1508,"price":11.54,"value":17402.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the \"net settlement\" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs."}],"balance_after":189275,"source":{"system":"sec-edgar","filing":"0001140361-24-009098","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036124009098/form4.xml","form_type":"4"}},{"id":1672998,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2024-01-24T02:00:29.000Z","date":"2024-01-20","kind":"tax_withholding","planned":true,"acquired":false,"shares":1506,"price":10.35,"value":15587.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the \"net settlement\" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs."}],"balance_after":190783,"source":{"system":"sec-edgar","filing":"0001140361-24-003549","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036124003549/form4.xml","form_type":"4"}},{"id":1697925,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Capped Value Appreciation Rights","published_at":"2023-12-30T02:00:16.000Z","date":"2023-12-27","kind":"exercise","planned":true,"acquired":false,"shares":1894,"price":11.5,"value":21781.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the conversion of capped value appreciation rights (\"CVARs\") that entitle the reporting person, following the achievement of specified vesting and other conditions, to an amount equal to the product of (i) the number of vested CVARs multiplied by (ii) the excess (if any) of (A) the fair market value of a Common Share (capped at $12.68 per share) as of the relevant date of determination over (B) the applicable hurdle price reflected in column 8 of Table II above (such excess, the \"CVAR Amount\"). On December 27, 2023, the hurdle price applicable to 1,894 of these vested CVARs has been satisfied and, accordingly, the CVARs were settled into 13 Common Shares, determined by dividing (i) the CVAR Amount by (ii) the closing price of a Common Share on December 27, 2023."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"This award of CVARs vests (i) 25% on the first anniversary of the vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date, with a vesting commencement date of December 27, 2019."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the conversion of capped value appreciation rights (\"CVARs\") that entitle the reporting person, following the achievement of specified vesting and other conditions, to an amount equal to the product of (i) the number of vested CVARs multiplied by (ii) the excess (if any) of (A) the fair market value of a Common Share (capped at $12.68 per share) as of the relevant date of determination over (B) the applicable hurdle price reflected in column 8 of Table II above (such excess, the \"CVAR Amount\"). On December 27, 2023, the hurdle price applicable to 1,894 of these vested CVARs has been satisfied and, accordingly, the CVARs were settled into 13 Common Shares, determined by dividing (i) the CVAR Amount by (ii) the closing price of a Common Share on December 27, 2023."},{"field":"shares","element":"transactionShares","label":"F3","text":"This award of CVARs vests (i) 25% on the first anniversary of the vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date, with a vesting commencement date of December 27, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the conversion of capped value appreciation rights (\"CVARs\") that entitle the reporting person, following the achievement of specified vesting and other conditions, to an amount equal to the product of (i) the number of vested CVARs multiplied by (ii) the excess (if any) of (A) the fair market value of a Common Share (capped at $12.68 per share) as of the relevant date of determination over (B) the applicable hurdle price reflected in column 8 of Table II above (such excess, the \"CVAR Amount\"). On December 27, 2023, the hurdle price applicable to 1,894 of these vested CVARs has been satisfied and, accordingly, the CVARs were settled into 13 Common Shares, determined by dividing (i) the CVAR Amount by (ii) the closing price of a Common Share on December 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This award of CVARs vests (i) 25% on the first anniversary of the vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date, with a vesting commencement date of December 27, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects the conversion of capped value appreciation rights (\"CVARs\") that entitle the reporting person, following the achievement of specified vesting and other conditions, to an amount equal to the product of (i) the number of vested CVARs multiplied by (ii) the excess (if any) of (A) the fair market value of a Common Share (capped at $12.68 per share) as of the relevant date of determination over (B) the applicable hurdle price reflected in column 8 of Table II above (such excess, the \"CVAR Amount\"). On December 27, 2023, the hurdle price applicable to 1,894 of these vested CVARs has been satisfied and, accordingly, the CVARs were settled into 13 Common Shares, determined by dividing (i) the CVAR Amount by (ii) the closing price of a Common Share on December 27, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This award of CVARs vests (i) 25% on the first anniversary of the vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date, with a vesting commencement date of December 27, 2019."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Reflects the conversion of capped value appreciation rights (\"CVARs\") that entitle the reporting person, following the achievement of specified vesting and other conditions, to an amount equal to the product of (i) the number of vested CVARs multiplied by (ii) the excess (if any) of (A) the fair market value of a Common Share (capped at $12.68 per share) as of the relevant date of determination over (B) the applicable hurdle price reflected in column 8 of Table II above (such excess, the \"CVAR Amount\"). On December 27, 2023, the hurdle price applicable to 1,894 of these vested CVARs has been satisfied and, accordingly, the CVARs were settled into 13 Common Shares, determined by dividing (i) the CVAR Amount by (ii) the closing price of a Common Share on December 27, 2023."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"This award of CVARs vests (i) 25% on the first anniversary of the vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date, with a vesting commencement date of December 27, 2019."}],"balance_after":87126,"derivative":{"expiration_date":"2026-03-31","underlying":"Common Shares","underlying_shares":13},"source":{"system":"sec-edgar","filing":"0001140361-23-060291","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123060291/form4.xml","form_type":"4"}},{"id":1697924,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-12-30T02:00:16.000Z","date":"2023-12-27","kind":"tax_withholding","planned":true,"acquired":false,"shares":6,"price":11.58,"value":69.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the \"net settlement\" by the Issuer of CVARs in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of the CVARs."}],"balance_after":192289,"source":{"system":"sec-edgar","filing":"0001140361-23-060291","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123060291/form4.xml","form_type":"4"}},{"id":1697923,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-12-30T02:00:16.000Z","date":"2023-12-27","kind":"exercise","planned":true,"acquired":true,"shares":13,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the conversion of capped value appreciation rights (\"CVARs\") that entitle the reporting person, following the achievement of specified vesting and other conditions, to an amount equal to the product of (i) the number of vested CVARs multiplied by (ii) the excess (if any) of (A) the fair market value of a Common Share (capped at $12.68 per share) as of the relevant date of determination over (B) the applicable hurdle price reflected in column 8 of Table II above (such excess, the \"CVAR Amount\"). On December 27, 2023, the hurdle price applicable to 1,894 of these vested CVARs has been satisfied and, accordingly, the CVARs were settled into 13 Common Shares, determined by dividing (i) the CVAR Amount by (ii) the closing price of a Common Share on December 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the conversion of capped value appreciation rights (\"CVARs\") that entitle the reporting person, following the achievement of specified vesting and other conditions, to an amount equal to the product of (i) the number of vested CVARs multiplied by (ii) the excess (if any) of (A) the fair market value of a Common Share (capped at $12.68 per share) as of the relevant date of determination over (B) the applicable hurdle price reflected in column 8 of Table II above (such excess, the \"CVAR Amount\"). On December 27, 2023, the hurdle price applicable to 1,894 of these vested CVARs has been satisfied and, accordingly, the CVARs were settled into 13 Common Shares, determined by dividing (i) the CVAR Amount by (ii) the closing price of a Common Share on December 27, 2023."}],"balance_after":192295,"source":{"system":"sec-edgar","filing":"0001140361-23-060291","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123060291/form4.xml","form_type":"4"}},{"id":1700892,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-12-23T00:00:18.000Z","date":"2023-12-20","kind":"tax_withholding","planned":true,"acquired":false,"shares":1364,"price":9.96,"value":13585.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the \"net settlement\" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs."}],"balance_after":192282,"source":{"system":"sec-edgar","filing":"0001140361-23-059239","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123059239/form4.xml","form_type":"4"}},{"id":1729499,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-11-28T02:30:23.000Z","date":"2023-11-22","kind":"other","planned":true,"acquired":false,"shares":1415,"price":8.68,"value":12282.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the sale of Common Shares pursuant to a \"sell-to-cover\" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units (\"RSUs\") previously granted to the reporting person. This sale was effected pursuant to a \"sell to cover\" policy entered into pursuant to the requirements of Rule 10b5-1 and does not represent a discretionary sale by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":193646,"source":{"system":"sec-edgar","filing":"0001140361-23-054758","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123054758/form4.xml","form_type":"4"}},{"id":1754709,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-10-27T01:30:25.000Z","date":"2023-10-24","kind":"other","planned":true,"acquired":false,"shares":1563,"price":8.99,"value":14051.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the sale of Common Shares pursuant to a \"sell-to-cover\" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units (\"RSUs\") previously granted to the reporting person. This sale was effected pursuant to a \"sell to cover\" policy entered into pursuant to the requirements of Rule 10b5-1 and does not represent a discretionary sale by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":195061,"source":{"system":"sec-edgar","filing":"0001140361-23-049765","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123049765/form4.xml","form_type":"4"}},{"id":1771498,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Capped Value Appreciation Rights","published_at":"2023-09-30T01:30:30.000Z","date":"2023-09-27","kind":"exercise","planned":false,"acquired":false,"shares":1894,"price":11.5,"value":21781.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the conversion of capped value appreciation rights (\"CVARs\") that entitle the reporting person, following the achievement of specified vesting and other conditions, to an amount equal to the product of (i) the number of vested CVARs multiplied by (ii) the excess (if any) of (A) the fair market value of a Common Share (capped at $12.68 per share) as of the relevant date of determination over (B) the applicable hurdle price reflected in column 8 of Table II above (such excess, the \"CVAR Amount\"). On September 27, 2023, the hurdle price applicable to 1,894 of these vested CVARs has been satisfied and, accordingly, the CVARs were settled into 169 Common Shares, determined by dividing (i) the CVAR Amount by (ii) the closing price of a Common Share on September 27, 2023."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"This award of CVARs vests (i) 25% on the first anniversary of the vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date, with a vesting commencement date of December 27, 2019."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the conversion of capped value appreciation rights (\"CVARs\") that entitle the reporting person, following the achievement of specified vesting and other conditions, to an amount equal to the product of (i) the number of vested CVARs multiplied by (ii) the excess (if any) of (A) the fair market value of a Common Share (capped at $12.68 per share) as of the relevant date of determination over (B) the applicable hurdle price reflected in column 8 of Table II above (such excess, the \"CVAR Amount\"). On September 27, 2023, the hurdle price applicable to 1,894 of these vested CVARs has been satisfied and, accordingly, the CVARs were settled into 169 Common Shares, determined by dividing (i) the CVAR Amount by (ii) the closing price of a Common Share on September 27, 2023."},{"field":"shares","element":"transactionShares","label":"F4","text":"This award of CVARs vests (i) 25% on the first anniversary of the vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date, with a vesting commencement date of December 27, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the conversion of capped value appreciation rights (\"CVARs\") that entitle the reporting person, following the achievement of specified vesting and other conditions, to an amount equal to the product of (i) the number of vested CVARs multiplied by (ii) the excess (if any) of (A) the fair market value of a Common Share (capped at $12.68 per share) as of the relevant date of determination over (B) the applicable hurdle price reflected in column 8 of Table II above (such excess, the \"CVAR Amount\"). On September 27, 2023, the hurdle price applicable to 1,894 of these vested CVARs has been satisfied and, accordingly, the CVARs were settled into 169 Common Shares, determined by dividing (i) the CVAR Amount by (ii) the closing price of a Common Share on September 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This award of CVARs vests (i) 25% on the first anniversary of the vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date, with a vesting commencement date of December 27, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects the conversion of capped value appreciation rights (\"CVARs\") that entitle the reporting person, following the achievement of specified vesting and other conditions, to an amount equal to the product of (i) the number of vested CVARs multiplied by (ii) the excess (if any) of (A) the fair market value of a Common Share (capped at $12.68 per share) as of the relevant date of determination over (B) the applicable hurdle price reflected in column 8 of Table II above (such excess, the \"CVAR Amount\"). On September 27, 2023, the hurdle price applicable to 1,894 of these vested CVARs has been satisfied and, accordingly, the CVARs were settled into 169 Common Shares, determined by dividing (i) the CVAR Amount by (ii) the closing price of a Common Share on September 27, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This award of CVARs vests (i) 25% on the first anniversary of the vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date, with a vesting commencement date of December 27, 2019."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Reflects the conversion of capped value appreciation rights (\"CVARs\") that entitle the reporting person, following the achievement of specified vesting and other conditions, to an amount equal to the product of (i) the number of vested CVARs multiplied by (ii) the excess (if any) of (A) the fair market value of a Common Share (capped at $12.68 per share) as of the relevant date of determination over (B) the applicable hurdle price reflected in column 8 of Table II above (such excess, the \"CVAR Amount\"). On September 27, 2023, the hurdle price applicable to 1,894 of these vested CVARs has been satisfied and, accordingly, the CVARs were settled into 169 Common Shares, determined by dividing (i) the CVAR Amount by (ii) the closing price of a Common Share on September 27, 2023."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"This award of CVARs vests (i) 25% on the first anniversary of the vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date, with a vesting commencement date of December 27, 2019."}],"balance_after":80020,"derivative":{"expiration_date":"2026-03-31","underlying":"Common Shares","underlying_shares":169},"source":{"system":"sec-edgar","filing":"0001140361-23-046106","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123046106/form4.xml","form_type":"4"}},{"id":1771497,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-09-30T01:30:30.000Z","date":"2023-09-28","kind":"other","planned":false,"acquired":false,"shares":92,"price":12.67,"value":1165.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the sale of Common Shares pursuant to a \"sell-to-cover\" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of the CVARs. This sale was effected pursuant to the issuer's \"sell to cover\" policy and does not represent a discretionary sale by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in this column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.25 to $13.20, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (3) to this Form 4."}],"balance_after":196624,"source":{"system":"sec-edgar","filing":"0001140361-23-046106","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123046106/form4.xml","form_type":"4"}},{"id":1771496,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-09-30T01:30:30.000Z","date":"2023-09-27","kind":"exercise","planned":false,"acquired":true,"shares":169,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the conversion of capped value appreciation rights (\"CVARs\") that entitle the reporting person, following the achievement of specified vesting and other conditions, to an amount equal to the product of (i) the number of vested CVARs multiplied by (ii) the excess (if any) of (A) the fair market value of a Common Share (capped at $12.68 per share) as of the relevant date of determination over (B) the applicable hurdle price reflected in column 8 of Table II above (such excess, the \"CVAR Amount\"). On September 27, 2023, the hurdle price applicable to 1,894 of these vested CVARs has been satisfied and, accordingly, the CVARs were settled into 169 Common Shares, determined by dividing (i) the CVAR Amount by (ii) the closing price of a Common Share on September 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the conversion of capped value appreciation rights (\"CVARs\") that entitle the reporting person, following the achievement of specified vesting and other conditions, to an amount equal to the product of (i) the number of vested CVARs multiplied by (ii) the excess (if any) of (A) the fair market value of a Common Share (capped at $12.68 per share) as of the relevant date of determination over (B) the applicable hurdle price reflected in column 8 of Table II above (such excess, the \"CVAR Amount\"). On September 27, 2023, the hurdle price applicable to 1,894 of these vested CVARs has been satisfied and, accordingly, the CVARs were settled into 169 Common Shares, determined by dividing (i) the CVAR Amount by (ii) the closing price of a Common Share on September 27, 2023."}],"balance_after":196716,"source":{"system":"sec-edgar","filing":"0001140361-23-046106","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123046106/form4.xml","form_type":"4"}},{"id":1773301,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-09-27T01:30:48.000Z","date":"2023-09-22","kind":"other","planned":false,"acquired":false,"shares":1403,"price":10.19,"value":14296.57,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the sale of Common Shares pursuant to a \"sell-to-cover\" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units (\"RSUs\") previously granted to the reporting person. This sale was effected pursuant to a \"sell to cover\" policy entered into pursuant to the requirements of Rule 10b5-1 and does not represent a discretionary sale by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":196547,"source":{"system":"sec-edgar","filing":"0001140361-23-045330","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123045330/form4.xml","form_type":"4"}},{"id":1782902,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-13T01:30:16.000Z","date":"2023-09-08","kind":"exercise","planned":false,"acquired":false,"shares":99350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of stock options to purchase Common Shares with a vesting commencement date of May 20, 2017. The award of stock options is fully vested"}],"balance_after":0,"derivative":{"exercise_price":6.48,"expiration_date":"2027-05-21","underlying":"Common Shares","underlying_shares":99350},"source":{"system":"sec-edgar","filing":"0001140361-23-043730","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123043730/form4.xml","form_type":"4"}},{"id":1782901,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-09-13T01:30:16.000Z","date":"2023-09-08","kind":"sale","planned":false,"acquired":false,"shares":99350,"price":12.18,"value":1210083.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2023."}],"balance_after":197950,"source":{"system":"sec-edgar","filing":"0001140361-23-043730","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123043730/form4.xml","form_type":"4"}},{"id":1782900,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-09-13T01:30:16.000Z","date":"2023-09-08","kind":"exercise","planned":false,"acquired":true,"shares":99350,"price":6.48,"value":643788.0,"ownership":{"direct":true},"balance_after":297300,"source":{"system":"sec-edgar","filing":"0001140361-23-043730","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123043730/form4.xml","form_type":"4"}},{"id":1785854,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-08T01:30:16.000Z","date":"2023-09-05","kind":"exercise","planned":false,"acquired":false,"shares":1724,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of stock options to purchase Common Shares with a vesting commencement date of May 20, 2017. The award of stock options is fully vested."}],"balance_after":99350,"derivative":{"exercise_price":6.48,"expiration_date":"2027-05-21","underlying":"Common Shares","underlying_shares":1724},"source":{"system":"sec-edgar","filing":"0001140361-23-043270","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123043270/form4.xml","form_type":"4"}},{"id":1785853,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-09-08T01:30:16.000Z","date":"2023-09-05","kind":"sale","planned":false,"acquired":false,"shares":1724,"price":12,"value":20688.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2023."}],"balance_after":197950,"source":{"system":"sec-edgar","filing":"0001140361-23-043270","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123043270/form4.xml","form_type":"4"}},{"id":1785852,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-09-08T01:30:16.000Z","date":"2023-09-05","kind":"exercise","planned":false,"acquired":true,"shares":1724,"price":6.48,"value":11171.52,"ownership":{"direct":true},"balance_after":199674,"source":{"system":"sec-edgar","filing":"0001140361-23-043270","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123043270/form4.xml","form_type":"4"}},{"id":1797697,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-08-25T01:30:40.000Z","date":"2023-08-22","kind":"other","planned":false,"acquired":false,"shares":1378,"price":10.83,"value":14923.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the sale of Common Shares pursuant to a \"sell-to-cover\" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units (\"RSUs\") previously granted to the reporting person. This sale was effected pursuant to a \"sell to cover\" policy entered into pursuant to the requirements of Rule 10b5-1 and does not represent a discretionary sale by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":197950,"source":{"system":"sec-edgar","filing":"0001140361-23-041199","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123041199/form4.xml","form_type":"4"}},{"id":1816356,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-04T01:30:42.000Z","date":"2023-08-03","kind":"exercise","planned":false,"acquired":false,"shares":3681,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of stock options to purchase Common Shares. The award of stock options is fully vested."}],"balance_after":101074,"derivative":{"exercise_price":6.48,"expiration_date":"2027-05-21","underlying":"Common Shares","underlying_shares":3681},"source":{"system":"sec-edgar","filing":"0001140361-23-037941","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123037941/form4.xml","form_type":"4"}},{"id":1816355,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-04T01:30:42.000Z","date":"2023-08-01","kind":"exercise","planned":false,"acquired":false,"shares":336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of stock options to purchase Common Shares. The award of stock options is fully vested."}],"balance_after":104755,"derivative":{"exercise_price":6.48,"expiration_date":"2027-05-21","underlying":"Common Shares","underlying_shares":336},"source":{"system":"sec-edgar","filing":"0001140361-23-037941","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123037941/form4.xml","form_type":"4"}},{"id":1816354,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-08-04T01:30:42.000Z","date":"2023-08-03","kind":"sale","planned":false,"acquired":false,"shares":3681,"price":12,"value":44172.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2023."}],"balance_after":199328,"source":{"system":"sec-edgar","filing":"0001140361-23-037941","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123037941/form4.xml","form_type":"4"}},{"id":1816353,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-08-04T01:30:42.000Z","date":"2023-08-03","kind":"exercise","planned":false,"acquired":true,"shares":3681,"price":6.48,"value":23852.88,"ownership":{"direct":true},"balance_after":203009,"source":{"system":"sec-edgar","filing":"0001140361-23-037941","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123037941/form4.xml","form_type":"4"}},{"id":1816352,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-08-04T01:30:42.000Z","date":"2023-08-01","kind":"sale","planned":false,"acquired":false,"shares":336,"price":12,"value":4032.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2023."}],"balance_after":199328,"source":{"system":"sec-edgar","filing":"0001140361-23-037941","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123037941/form4.xml","form_type":"4"}},{"id":1816351,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-08-04T01:30:42.000Z","date":"2023-08-01","kind":"exercise","planned":false,"acquired":true,"shares":336,"price":6.48,"value":2177.28,"ownership":{"direct":true},"balance_after":199664,"source":{"system":"sec-edgar","filing":"0001140361-23-037941","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123037941/form4.xml","form_type":"4"}},{"id":1822811,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-07-27T01:30:18.000Z","date":"2023-07-24","kind":"other","planned":false,"acquired":false,"shares":1393,"price":10.99,"value":15309.07,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the sale of Common Shares pursuant to a \"sell-to-cover\" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units (\"RSUs\") previously granted to the reporting person. This sale was effected pursuant to a \"sell to cover\" policy entered into pursuant to the requirements of Rule 10b5-1 and does not represent a discretionary sale by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":199328,"source":{"system":"sec-edgar","filing":"0001140361-23-036309","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123036309/form4.xml","form_type":"4"}},{"id":1827797,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-19T01:30:27.000Z","date":"2023-07-18","kind":"exercise","planned":false,"acquired":false,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Award of stock options to purchase Common Shares with a vesting commencement date of May 20, 2017. The award of stock options is fully vested."}],"balance_after":105091,"derivative":{"exercise_price":6.48,"expiration_date":"2027-05-21","underlying":"Common Shares","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0001140361-23-035096","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123035096/form4.xml","form_type":"4"}},{"id":1827796,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-19T01:30:27.000Z","date":"2023-07-14","kind":"exercise","planned":false,"acquired":false,"shares":535,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Award of stock options to purchase Common Shares with a vesting commencement date of May 20, 2017. The award of stock options is fully vested."}],"balance_after":105191,"derivative":{"exercise_price":6.48,"expiration_date":"2027-05-21","underlying":"Common Shares","underlying_shares":535},"source":{"system":"sec-edgar","filing":"0001140361-23-035096","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123035096/form4.xml","form_type":"4"}},{"id":1827795,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-07-19T01:30:27.000Z","date":"2023-07-18","kind":"sale","planned":false,"acquired":false,"shares":100,"price":12,"value":1200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes Common Shares purchased under the Company's Employee Stock Purchase Plan."}],"balance_after":82128,"source":{"system":"sec-edgar","filing":"0001140361-23-035096","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123035096/form4.xml","form_type":"4"}},{"id":1827794,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-07-19T01:30:27.000Z","date":"2023-07-18","kind":"exercise","planned":false,"acquired":true,"shares":100,"price":6.48,"value":648.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes Common Shares purchased under the Company's Employee Stock Purchase Plan."}],"balance_after":82228,"source":{"system":"sec-edgar","filing":"0001140361-23-035096","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123035096/form4.xml","form_type":"4"}},{"id":1827793,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-07-19T01:30:27.000Z","date":"2023-07-14","kind":"sale","planned":false,"acquired":false,"shares":535,"price":12,"value":6420.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes Common Shares purchased under the Company's Employee Stock Purchase Plan."}],"balance_after":82128,"source":{"system":"sec-edgar","filing":"0001140361-23-035096","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123035096/form4.xml","form_type":"4"}},{"id":1827792,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-07-19T01:30:27.000Z","date":"2023-07-14","kind":"exercise","planned":false,"acquired":true,"shares":535,"price":6.48,"value":3466.8,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes Common Shares purchased under the Company's Employee Stock Purchase Plan."}],"balance_after":82663,"source":{"system":"sec-edgar","filing":"0001140361-23-035096","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123035096/form4.xml","form_type":"4"}},{"id":1844195,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-06-27T01:31:05.000Z","date":"2023-06-22","kind":"other","planned":false,"acquired":false,"shares":1357,"price":10.01,"value":13583.57,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the sale of Common Shares pursuant to a \"sell-to-cover\" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units (\"RSUs\") previously granted to the reporting person. This sale was effected pursuant to a \"sell to cover\" policy entered into pursuant to the requirements of Rule 10b5-1 and does not represent a discretionary sale by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":197225,"source":{"system":"sec-edgar","filing":"0001140361-23-031546","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123031546/form4.xml","form_type":"4"}},{"id":1855555,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Rt to Buy)","published_at":"2023-06-14T20:56:19.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":27380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable."}],"balance_after":27380,"derivative":{"exercise_price":4.2,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":27380},"source":{"system":"sec-edgar","filing":"0001209191-23-037074","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528287/000120919123037074/doc4.xml","form_type":"4"}},{"id":1857199,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-14T01:31:00.000Z","date":"2023-06-09","kind":"exercise","planned":false,"acquired":false,"shares":43893,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of stock options to purchase Common Shares with a vesting commencement date of December 30, 2015. The award of stock options is fully vested."}],"balance_after":0,"derivative":{"exercise_price":5.12,"expiration_date":"2025-12-29","underlying":"Common Shares","underlying_shares":43893},"source":{"system":"sec-edgar","filing":"0001140361-23-029728","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123029728/form4.xml","form_type":"4"}},{"id":1857198,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-06-14T01:31:00.000Z","date":"2023-06-09","kind":"sale","planned":false,"acquired":false,"shares":43893,"price":9.93,"value":435857.49,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2023."}],"balance_after":198582,"source":{"system":"sec-edgar","filing":"0001140361-23-029728","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123029728/form4.xml","form_type":"4"}},{"id":1857197,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-06-14T01:31:00.000Z","date":"2023-06-09","kind":"exercise","planned":false,"acquired":true,"shares":43893,"price":5.12,"value":224732.16,"ownership":{"direct":true},"balance_after":242475,"source":{"system":"sec-edgar","filing":"0001140361-23-029728","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123029728/form4.xml","form_type":"4"}},{"id":1878083,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-05-26T01:31:12.000Z","date":"2023-05-23","kind":"other","planned":false,"acquired":false,"shares":1557,"price":9.58,"value":14916.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the sale of Common Shares pursuant to a \"sell-to-cover\" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units (\"RSUs\") previously granted to the reporting person. This sale was effected pursuant to a \"sell to cover\" policy entered into pursuant to the requirements of Rule 10b5-1 and does not represent a discretionary sale by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":198582,"source":{"system":"sec-edgar","filing":"0001140361-23-026782","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123026782/form4.xml","form_type":"4"}},{"id":1906115,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-04T01:30:47.000Z","date":"2023-05-02","kind":"exercise","planned":true,"acquired":false,"shares":15517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2022. These options vest and become exercisable (i) 25% on the first anniversary of the applicable vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject generally to the reporting person's continuous service through each vesting date (unless otherwise provided in the applicable award documentation)."}],"balance_after":750000,"derivative":{"exercise_price":3.85,"expiration_date":"2032-04-19","underlying":"Common Shares","underlying_shares":15517},"source":{"system":"sec-edgar","filing":"0001140361-23-022809","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123022809/form4.xml","form_type":"4"}},{"id":1906114,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-04T01:30:47.000Z","date":"2023-05-01","kind":"exercise","planned":true,"acquired":false,"shares":62219,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2022. These options vest and become exercisable (i) 25% on the first anniversary of the applicable vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject generally to the reporting person's continuous service through each vesting date (unless otherwise provided in the applicable award documentation)."}],"balance_after":765517,"derivative":{"exercise_price":3.85,"expiration_date":"2032-04-19","underlying":"Common Shares","underlying_shares":62219},"source":{"system":"sec-edgar","filing":"0001140361-23-022809","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123022809/form4.xml","form_type":"4"}},{"id":1906113,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-05-04T01:30:47.000Z","date":"2023-05-02","kind":"sale","planned":true,"acquired":false,"shares":15517,"price":8.42,"value":130653.14,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2023."}],"balance_after":200139,"source":{"system":"sec-edgar","filing":"0001140361-23-022809","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123022809/form4.xml","form_type":"4"}},{"id":1906112,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-05-04T01:30:47.000Z","date":"2023-05-02","kind":"exercise","planned":true,"acquired":true,"shares":15517,"price":3.85,"value":59740.45,"ownership":{"direct":true},"balance_after":215656,"source":{"system":"sec-edgar","filing":"0001140361-23-022809","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123022809/form4.xml","form_type":"4"}},{"id":1906111,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-05-04T01:30:47.000Z","date":"2023-05-01","kind":"sale","planned":true,"acquired":false,"shares":62219,"price":8.58,"value":533839.02,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2023."}],"balance_after":200139,"source":{"system":"sec-edgar","filing":"0001140361-23-022809","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123022809/form4.xml","form_type":"4"}},{"id":1906110,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-05-04T01:30:47.000Z","date":"2023-05-01","kind":"exercise","planned":true,"acquired":true,"shares":62219,"price":3.85,"value":239543.15,"ownership":{"direct":true},"balance_after":262358,"source":{"system":"sec-edgar","filing":"0001140361-23-022809","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123022809/form4.xml","form_type":"4"}},{"id":1911295,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-29T01:35:43.000Z","date":"2023-04-28","kind":"exercise","planned":true,"acquired":false,"shares":71989,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2022. These options vest and become exercisable (i) 25% on the first anniversary of the applicable vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject generally to the reporting person's continuous service through each vesting date (unless otherwise provided in the applicable award documentation)."}],"balance_after":827736,"derivative":{"exercise_price":3.85,"expiration_date":"2032-04-19","underlying":"Common Shares","underlying_shares":71989},"source":{"system":"sec-edgar","filing":"0001140361-23-021749","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123021749/form4.xml","form_type":"4"}},{"id":1911294,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-29T01:35:43.000Z","date":"2023-04-27","kind":"exercise","planned":true,"acquired":false,"shares":65634,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2022. These options vest and become exercisable (i) 25% on the first anniversary of the applicable vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject generally to the reporting person's continuous service through each vesting date (unless otherwise provided in the applicable award documentation)."}],"balance_after":899725,"derivative":{"exercise_price":3.85,"expiration_date":"2032-04-19","underlying":"Common Shares","underlying_shares":65634},"source":{"system":"sec-edgar","filing":"0001140361-23-021749","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123021749/form4.xml","form_type":"4"}},{"id":1911293,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-29T01:35:43.000Z","date":"2023-04-27","kind":"exercise","planned":true,"acquired":false,"shares":5335,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of stock options to purchase Common Shares that was fully vested."}],"balance_after":0,"derivative":{"exercise_price":3.97,"expiration_date":"2026-05-19","underlying":"Common Shares","underlying_shares":5335},"source":{"system":"sec-edgar","filing":"0001140361-23-021749","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123021749/form4.xml","form_type":"4"}},{"id":1911292,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-29T01:35:43.000Z","date":"2023-04-26","kind":"exercise","planned":true,"acquired":false,"shares":34641,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2022. These options vest and become exercisable (i) 25% on the first anniversary of the applicable vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject generally to the reporting person's continuous service through each vesting date (unless otherwise provided in the applicable award documentation)."}],"balance_after":965359,"derivative":{"exercise_price":3.85,"expiration_date":"2032-04-19","underlying":"Common Shares","underlying_shares":34641},"source":{"system":"sec-edgar","filing":"0001140361-23-021749","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123021749/form4.xml","form_type":"4"}},{"id":1911291,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-29T01:35:43.000Z","date":"2023-04-26","kind":"exercise","planned":true,"acquired":false,"shares":53189,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of stock options to purchase Common Shares that was fully vested."}],"balance_after":5335,"derivative":{"exercise_price":3.97,"expiration_date":"2026-05-19","underlying":"Common Shares","underlying_shares":53189},"source":{"system":"sec-edgar","filing":"0001140361-23-021749","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123021749/form4.xml","form_type":"4"}},{"id":1911290,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-04-29T01:35:43.000Z","date":"2023-04-28","kind":"sale","planned":true,"acquired":false,"shares":71989,"price":8.47,"value":609746.83,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2023."}],"balance_after":200139,"source":{"system":"sec-edgar","filing":"0001140361-23-021749","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123021749/form4.xml","form_type":"4"}},{"id":1911289,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-04-29T01:35:43.000Z","date":"2023-04-28","kind":"exercise","planned":true,"acquired":true,"shares":71989,"price":3.85,"value":277157.65,"ownership":{"direct":true},"balance_after":272128,"source":{"system":"sec-edgar","filing":"0001140361-23-021749","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123021749/form4.xml","form_type":"4"}},{"id":1911288,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-04-29T01:35:43.000Z","date":"2023-04-27","kind":"sale","planned":true,"acquired":false,"shares":70969,"price":8.51,"value":603946.19,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2023."}],"balance_after":200139,"source":{"system":"sec-edgar","filing":"0001140361-23-021749","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123021749/form4.xml","form_type":"4"}},{"id":1911287,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-04-29T01:35:43.000Z","date":"2023-04-27","kind":"exercise","planned":true,"acquired":true,"shares":65634,"price":3.85,"value":252690.9,"ownership":{"direct":true},"balance_after":271108,"source":{"system":"sec-edgar","filing":"0001140361-23-021749","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123021749/form4.xml","form_type":"4"}},{"id":1911286,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-04-29T01:35:43.000Z","date":"2023-04-27","kind":"exercise","planned":true,"acquired":true,"shares":5335,"price":3.97,"value":21179.95,"ownership":{"direct":true},"balance_after":205474,"source":{"system":"sec-edgar","filing":"0001140361-23-021749","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123021749/form4.xml","form_type":"4"}},{"id":1911285,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-04-29T01:35:43.000Z","date":"2023-04-26","kind":"sale","planned":true,"acquired":false,"shares":87830,"price":8.68,"value":762364.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2023."}],"balance_after":200139,"source":{"system":"sec-edgar","filing":"0001140361-23-021749","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123021749/form4.xml","form_type":"4"}},{"id":1911284,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-04-29T01:35:43.000Z","date":"2023-04-26","kind":"exercise","planned":true,"acquired":true,"shares":34641,"price":3.85,"value":133367.85,"ownership":{"direct":true},"balance_after":287969,"source":{"system":"sec-edgar","filing":"0001140361-23-021749","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123021749/form4.xml","form_type":"4"}},{"id":1911283,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-04-29T01:35:43.000Z","date":"2023-04-26","kind":"exercise","planned":true,"acquired":true,"shares":53189,"price":3.97,"value":211160.33,"ownership":{"direct":true},"balance_after":253328,"source":{"system":"sec-edgar","filing":"0001140361-23-021749","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123021749/form4.xml","form_type":"4"}},{"id":1914882,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-25T01:28:16.000Z","date":"2023-04-20","kind":"grant","planned":false,"acquired":true,"shares":286408,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2023. These options vest and become exercisable (i) 25% on the first anniversary of the vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date."}],"balance_after":286408,"derivative":{"exercise_price":8.8,"expiration_date":"2033-04-19","underlying":"Common Shares","underlying_shares":286408},"source":{"system":"sec-edgar","filing":"0001140361-23-019992","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123019992/form4.xml","form_type":"4"}},{"id":1914881,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-04-25T01:28:16.000Z","date":"2023-04-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":1569,"price":8.8,"value":13807.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the \"net settlement\" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes Common Shares purchased under the Company's Employee Stock Purchase Plan."}],"balance_after":200139,"source":{"system":"sec-edgar","filing":"0001140361-23-019992","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123019992/form4.xml","form_type":"4"}},{"id":1914880,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-04-25T01:28:16.000Z","date":"2023-04-20","kind":"grant","planned":false,"acquired":true,"shares":66710,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an award of 66,710 restricted stock units with respect to Common Shares (\"RSUs\") with a vesting commencement date of April 20, 2023. 1/4 of the RSUs service-vest twelve (12) months after the vesting commencement date; 1/16 of the RSUs service-vest fourteen (14) months after the vesting commencement date; and the balance of the RSUs service-vest in a series of eleven (11) successive equal quarterly installments measured from the date fourteen (14) months after the vesting commencement date, subject to the reporting person's Continuous Service through the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes Common Shares purchased under the Company's Employee Stock Purchase Plan."}],"balance_after":201708,"source":{"system":"sec-edgar","filing":"0001140361-23-019992","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123019992/form4.xml","form_type":"4"}},{"id":1937876,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-03-28T01:30:21.000Z","date":"2023-03-23","kind":"other","planned":false,"acquired":false,"shares":2134,"price":7.3,"value":15578.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the sale of Common Shares pursuant to a \"sell-to-cover\" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units (\"RSUs\") previously granted to the reporting person. This sale was effected pursuant to a \"sell to cover\" policy entered into pursuant to the requirements of Rule 10b5-1 and does not represent a discretionary sale by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":130409,"source":{"system":"sec-edgar","filing":"0001140361-23-014075","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123014075/form4.xml","form_type":"4"}},{"id":1993181,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-02-25T02:30:48.000Z","date":"2023-02-22","kind":"other","acquired":false,"shares":1797,"price":8.43,"value":15148.71,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the sale of Common Shares pursuant to a \"sell-to-cover\" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units (\"RSUs\") previously granted to the reporting person. This sale was effected pursuant to a \"sell to cover\" policy entered into pursuant to the requirements of Rule 10b5-1 and does not represent a discretionary sale by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":132543,"source":{"system":"sec-edgar","filing":"0001140361-23-008668","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123008668/form4.xml","form_type":"4"}},{"id":2044987,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":36254,"kind":"person","name":"Kumar Rakhi","position":1,"cik":"0001856296","reported_name":"Kumar Rakhi","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2023-01-27T02:01:17.000Z","date":"2023-01-24","kind":"other","acquired":false,"shares":1838,"price":8.56,"value":15733.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the sale of Common Shares pursuant to a \"sell-to-cover\" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units (\"RSUs\") previously granted to the reporting person. This sale was effected pursuant to a \"sell to cover\" policy entered into pursuant to the requirements of Rule 10b5-1 and does not represent a discretionary sale by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":134340,"source":{"system":"sec-edgar","filing":"0001140361-23-002959","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123002959/form4.xml","form_type":"4"}}],"next_cursor":"2023-01-27T02:01:17.000000Z,2044987"}